Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicenter, randomized, double-blind, placebo-controlled trial and LOFT Extension Study
McClung, M.R., O'Donoghue, M.L., Papapoulos, S.E., Bone, H., Langdahl, B., Saag, K.G., Reid, I.R., Cavallari, I., Bonaca, M.P., Wiviott, S.D., de Villers, T., Ling, X., Lippuner, K., Nakamura, T., Reginster, Jean-Yves, Rodrigez-Portales, J.A., Roux, C., Zanchetta, J., Zerbini, C.A.F., Park, J.G., Cange, A., Grip, L.T., Heyden, N., DaSilva, C., Cohn, D., Massaad, R., Scott, B.B., Verbruggen, N., Gurner, D, Miller, D.L., Blair, M.L., Polis, A.B., Stoch, S.A., Santora, A., Lombardi, A., Leung, A.T., Kaufman, K.D., Sabatine, M.S., LOFT Ivestigators
Year of Publication 19.10.2019
Year of Publication 19.10.2019
Get full text
Web Resource